Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Depression × Saline Solution × Clear all

Phase

Phase NA 3 Phase 4 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 3 Neoplasms 2 Urinary Bladder Neoplasms 1 Spinal Cord Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion 1 Liver Neoplasms 1 Depression 1 Carcinoma, Hepatocellular 1

Interventions

Oxygen 2 Melatonin 2 Ultraviolet Therapy 1 Surveys and Questionnaires 1 Saline Solution 1 Referral and Consultation 1 Mindfulness-Based Stress Reduction 1 Methylphenidate 1 Ketamine 1 Fatty Acids, Omega-3 1 Desvenlafaxine Succinate 1 Cognitive Behavioral Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03086148 2020-07-07

Ketamine and Postoperative Depressive Symptom-PASSION

Beijing Tiantan Hospital

Phase 2/3 Completed

Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡